Workshop on molecular targets for cancer, Luxembourg
The discovery of novel molecular targets for many of the most frequent cancers (lung, breast, colorectal, stomach, prostate, pancreatic and bladder cancer) will enable diagnosis at earlier stages of the disease and have a profound impact on treatment selection for individual patients. Cancer biomarkers may also have the potential to serve as targets for the development of new anti-cancer therapies and innovative treatment strategies. Finally, accurate markers will help in assessing the progression of disease, giving the clinician better information and help in deciding the best possible therapy.
The workshop aims to identify possible bottlenecks in identifying and validating molecular targets, and put forward solutions that boost the commercial value of innovative findings on molecular targets arising from European cancer research.For more information, please visit:
http://www.ccrn.lu/cancer/(opens in new window)